{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:43:57Z","timestamp":1792712637435,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020205","name":"Health Commission of Jiangxi Province","doi-asserted-by":"publisher","award":["2024ZD007"],"award-info":[{"award-number":["2024ZD007"]}],"id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.lfs.2025.124144","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:20:57Z","timestamp":1765239657000},"page":"124144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Interleukin-35 alleviates pulmonary arterial hypertension by suppressing the VEGFA\/VEGFR2 signaling pathway"],"prefix":"10.1016","volume":"385","author":[{"given":"Jie","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmam","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3042-271X","authenticated-orcid":false,"given":"Yanqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2025.124144_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2023.104168","article-title":"Pulmonary arterial hypertension","volume":"52","author":"Boucly","year":"2023","journal-title":"Presse Med."},{"issue":"2","key":"10.1016\/j.lfs.2025.124144_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41569-024-01064-4","article-title":"Mechanisms and treatment of pulmonary arterial hypertension","volume":"22","author":"Ghofrani","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"issue":"22","key":"10.1016\/j.lfs.2025.124144_bb0015","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.jacc.2020.10.007","article-title":"Cardiopulmonary hemodynamics in pulmonary hypertension and heart failure: JACC review topic of the week","volume":"76","author":"Maron","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2025.124144_bb0020","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.chest.2025.05.009","article-title":"Best practices for right heart catheterization in the diagnosis of pulmonary hypertension","volume":"168","author":"Matusov","year":"2025","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.lfs.2025.124144_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094554","article-title":"Structural and hemodynamic changes of the right ventricle in PH-HFpEF","volume":"23","author":"Barilli","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.lfs.2025.124144_bb0030","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp","year":"2022","journal-title":"Jama"},{"issue":"3 Suppl","key":"10.1016\/j.lfs.2025.124144_bb0035","article-title":"Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients","volume":"27","author":"Levine","year":"2021","journal-title":"Am. J. Manag. Care"},{"issue":"38","key":"10.1016\/j.lfs.2025.124144_bb0040","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2025.124144_bb0045","article-title":"Global, regional, and national trends in pulmonary arterial hypertension burden, 1990-2021: findings from the global burden of disease study 2021","volume":"13","author":"Liu","year":"2025","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.lfs.2025.124144_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(24)00295-9","article-title":"Global, regional, and national burden of pulmonary arterial hypertension, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"13","author":"Leary","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2025.124144_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108938","article-title":"Interleukin-35 ameliorates cardiovascular disease by suppressing inflammatory responses and regulating immune homeostasis","volume":"110","author":"Feng","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2025.124144_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106238","article-title":"Immunity and inflammation in pulmonary arterial hypertension: from pathophysiology mechanisms to treatment perspective","volume":"180","author":"Wang","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.lfs.2025.124144_bb0065","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41590-019-0389-y","article-title":"T(reg) cell IL-10 and IL-35 exhaust CD8(+) T cells in tumors","volume":"20","author":"Damo","year":"2019","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2025.124144_bb0070","doi-asserted-by":"crossref","DOI":"10.21037\/atm-21-1952","article-title":"Tregs-derived interleukin 35 attenuates endothelial proliferation through STAT1 in pulmonary hypertension","volume":"9","author":"Wan","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"6","key":"10.1016\/j.lfs.2025.124144_bb0075","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cellsig.2011.01.024","article-title":"The LAR protein tyrosine phosphatase enables PDGF \u03b2-receptor activation through attenuation of the c-Abl kinase activity","volume":"23","author":"Zheng","year":"2011","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.lfs.2025.124144_bb0080","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3390\/biomedicines12091944","article-title":"The monocrotaline rat model of right heart disease induced by pulmonary artery hypertension","volume":"12","author":"Krstic","year":"2024","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.lfs.2025.124144_bb0085","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/trf.15805","article-title":"rIL-35 prevents murine transfusion-related acute lung injury by inhibiting the activation of endothelial cells","volume":"60","author":"Qiao","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.lfs.2025.124144_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.176469","article-title":"Airborne polystyrene nanoplastics exposure leads to heart failure via ECM-receptor interaction and PI3K\/AKT\/BCL-2 pathways","volume":"954","author":"Chang","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.lfs.2025.124144_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177934","article-title":"Programmed cell death: a pivotal player in pulmonary arterial hypertension","volume":"1003","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124144_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmed.2016.11.005","article-title":"Targeting vascular remodeling to treat pulmonary arterial hypertension","volume":"23","author":"Thompson","year":"2017","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.124144_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/mps5010013","article-title":"A one-stop protocol to assess myocardial fibrosis in frozen and paraffin sections","volume":"5","author":"Sridharan","year":"2022","journal-title":"Methods Protoc."},{"key":"10.1016\/j.lfs.2025.124144_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122862","article-title":"The antihypertensive effect of alizarin is achieved by activating VEGFR2\/eNOS pathway, attenuating oxidative stress-induced mitochondrial damage and premature senescence","volume":"351","author":"Qian","year":"2024","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.lfs.2025.124144_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101236","article-title":"Recent advances and future prospects of treatment of pulmonary hypertension","volume":"48","author":"Hajra","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2025.124144_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.201201-0164OC","article-title":"Modern age pathology of pulmonary arterial hypertension","volume":"186","author":"Stacher","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.124144_bb0125","article-title":"Interleukin-6 and pulmonary hypertension: from physiopathology to therapy","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.124144_bb0130","article-title":"SOX17 prevents endothelial-mesenchymal transition of pulmonary arterial endothelial cells in pulmonary hypertension through mediating TGF-\u03b2\/Smad2\/3 signaling","author":"Zou","year":"2024","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.lfs.2025.124144_bb0135","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s40259-024-00680-3","article-title":"Pulmonary arterial hypertension and TGF-\u03b2 superfamily signaling: focus on Sotatercept","volume":"38","author":"Stump","year":"2024","journal-title":"BioDrugs"},{"issue":"17","key":"10.1016\/j.lfs.2025.124144_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13174977","article-title":"Circulating endothelin 1 but not transforming growth factor-\u03b2 levels are reduced after pulmonary endarterectomy in subjects affected by chronic thromboembolic pulmonary hypertension: a prospective cohort study","volume":"13","author":"Totaro","year":"2024","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.lfs.2025.124144_bb0145","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1111\/bph.14375","article-title":"Inflammasomes: a novel therapeutic target in pulmonary hypertension?","volume":"176","author":"Scott","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2025.124144_bb0150","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1183\/13993003.01448-2015","article-title":"Role of interleukin-1 receptor 1\/MyD88 signalling in the development and progression of pulmonary hypertension","volume":"48","author":"Parpaleix","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.lfs.2025.124144_bb0155","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1164\/rccm.201809-1631LE","article-title":"IL-1 blockade reduces inflammation in pulmonary arterial hypertension and right ventricular failure: a single-arm, open-label, phase IB\/II pilot study","volume":"199","author":"Trankle","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.124144_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.abb.2011.06.005","article-title":"Role of TGF-\u03b21 and TNF-\u03b1 in IL-1\u03b2 mediated activation of proMMP-9 in pulmonary artery smooth muscle cells: involvement of an aprotinin sensitive protease","volume":"513","author":"Roy","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"issue":"6","key":"10.1016\/j.lfs.2025.124144_bb0165","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/fcp.12666","article-title":"Transforming growth factor-\u03b21 inhibits interleukin-1\u03b2-induced expression of inflammatory genes and Cathepsin S activity in human vascular smooth muscle cells","volume":"35","author":"Dhaouadi","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124144_bb0170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12931-021-01808-7","article-title":"IL-1\u03b2 augments TGF-\u03b2 inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics","volume":"22","author":"Zhang","year":"2021","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.124144_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2019.01.007","article-title":"Endothelin-1 levels and cardiovascular events","volume":"30","author":"Jankowich","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.lfs.2025.124144_bb0180","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jacbts.2024.04.005","article-title":"Targeting soluble TGF-\u03b2 factors: Advances in precision therapy for pulmonary arterial hypertension","volume":"9","author":"Becher","year":"2024","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.lfs.2025.124144_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111567","article-title":"IL-35 ameliorates lipopolysaccharide-induced endothelial dysfunction by inhibiting endothelial-to-mesenchymal transition","volume":"129","author":"Feng","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2025.124144_bb0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.intimp.2017.06.015","article-title":"An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection","volume":"50","author":"Liu","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2025.124144_bb0195","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s44161-023-00347-2","article-title":"Current and future strategies for targeting the endothelin pathway in cardiovascular disease","volume":"2","author":"Abraham","year":"2023","journal-title":"Nature Cardiovascular Research"},{"key":"10.1016\/j.lfs.2025.124144_bb0200","article-title":"Role of macrophages in pulmonary arterial hypertension","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124144_bb0205","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12931-024-03058-9","article-title":"T follicular helper cell is essential for M2 macrophage polarization and pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension","volume":"25","author":"Li","year":"2024","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.lfs.2025.124144_bb0210","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12079-016-0352-8","article-title":"VEGF-A\/VEGFR2 signaling network in endothelial cells relevant to angiogenesis","volume":"10","author":"Abhinand","year":"2016","journal-title":"J. Cell Commun. Signal."},{"issue":"24","key":"10.1016\/j.lfs.2025.124144_bb0215","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/CIRCULATIONAHA.122.061900","article-title":"Targeting VEGF-A\/VEGFR2 Y949 signaling-mediated vascular permeability alleviates hypoxic pulmonary hypertension","volume":"146","author":"Zhou","year":"2022","journal-title":"Circulation"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525007805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525007805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:31:09Z","timestamp":1768393869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525007805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"alternative-id":["S0024320525007805"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124144","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-35 alleviates pulmonary arterial hypertension by suppressing the VEGFA\/VEGFR2 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"124144"}}